Commercialisation models for Virtual Care in Respiratory Diseases

 Chronic Respiratory Diseases such as COPD and asthma are highly prevalent and lead to a large number of deaths every year. Remote Patient Monitoring (RPM) has been shown to be helpful for the prevention of COPD and asthma exacerbations as well as in the management of these conditions. These tools can also reduce costs for health systems and payers (fewer hospitalizations, ER visits and readmissions). But beyond evidence and outcomes, choosing the right route to market is a big challenge for digital health companies operating in this space. Join us in this informal conversation where we will discuss: